Low Level Laser Therapy in Discogenic Lumber Radiculopathy

The effectiveness of Low Level Laser Therapy in Discogenic Lumber Radiculopathy; A Double Blind Randomized Controlled Clinical Trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190707044128N2

Enrollment

140

Registered

2020-03-13

Start date

2020-02-15

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation is a displacement / protrusion of disc material (nucleus pulposus or annulus fibrosis) beyond the intervertebral disc space. The prolapsed nucleus pulposus will often come in contact with the nearby spinal nerves, results in the compression of these nerves which in turn results in severe radicular pain. Herniated discs are the common cause of lower back pain (LBP), hip and leg pain. The onset of pain may begin suddenly or gradually after injury. Typically, the pain is loca

Interventions

Intervention 1: Intervention group: Group-A of 70 patients will be treated with Low level Laser Therapy (LLLT) -830nm, 0.67 W/cm2 or 300 mW/cm2 at (Lumber-4,5 and Sacral-1 area) and Conventional Physi

Eligibility

Sex/Gender

All

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age group between 25- 50 years Both male and female patients Newly diagnosed cases of discogenic lumbar radiculopathy Patients with at least moderate score (21%-40%) in Oswestry Disability Index Patients with positive SLR or Lasegue's test

Exclusion criteria

Exclusion criteria: Patients receiving treatment by other methods like vapocoolants, dry needling, laser acupuncture, subdural steroid injections etc. for the last 3 months Lumbar spine surgery within the past year Spondylolisthesis Ankylosing spondylitis Vascular, neurological or rheumatic disorders Clinical evidence of any myelopathy or joint disorders Recent fracture of the lumbar vertebral spine Cauda equina syndrome Osteoporosis Clinical evidence of any tumor or any space occupying lesion. Any co-morbid diseases

Design outcomes

Primary

Measure	Time frame
Pain Intensity. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: Visual Analogue Scale (VAS).;Functional Disability. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: ODI (Oswestry Disability Index).;Lumber Range of Motion. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: Dual Inclinometer.	—

Measure

Time frame

Pain Intensity. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: Visual Analogue Scale (VAS).;Functional Disability. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: ODI (Oswestry Disability Index).;Lumber Range of Motion. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: Dual Inclinometer.

—

Secondary

Measure	Time frame
Sciatic Nerve mobility. Timepoint: At the start of treatment and then after 18 treatment sessions for each patient. Method of measurement: Straight Leg Raise or Lasegue's Test.	—

Countries

Pakistan

Contacts

Public ContactDr. Ishaq Ahmed

The University of Lahore

ishaqpt786@gmail.com+92 51 4486422-6

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026